Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Immunocore Holdings plc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +3 vs. Q3 2021
- Shares held
- 17.7M
- +1.08M (+6.5%) vs. Q3 2021
- Total value
- $642.4M
- +$26.0M (+4.2%) vs. Q3 2021
- New holders
- 9
- 13 more added
- Sold out
- 6
- 14 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 2,520,730 | $86.3M | 0.42% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 2,471,555 | $84.6M | 1.96% | +26,400+1.1% | Added |
| FMR LLC | 2,123,327 | $72.7M | 0.01% | −57,659−2.6% | Reduced |
| Bill & Melinda Gates Foundation | 576,923 | $55.8M | 16.93% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,414,150 | $48.4M | 0.01% | +362,075+34.4% | Added |
| RTW Investments, LP | 1,245,532 | $42.6M | 0.62% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,230,000 | $42.1M | 0.89% | +134,400+12.3% | Added |
| General Atlantic LLC | 950,000 | $32.5M | 0.25% | 00.0% | Unchanged |
| Bain Capital Public Equity Management II, LLC | 711,951 | $24.4M | 0.89% | +73,746+11.6% | Added |
| First Manhattan Co | 509,856 | $17.5M | 0.06% | +311,857+157.5% | Added |
| BlackRock Inc. | 496,182 | $17.0M | 0.00% | −331,422−40.0% | Reduced |
| Price T Rowe Associates Inc | 379,891 | $13.0M | 0.00% | +17,865+4.9% | Added |
| Perceptive Advisors LLC | 360,000 | $12.3M | 0.19% | −40,000−10.0% | Reduced |
| Thrivent Financial for Lutherans | 355,083 | $12.2M | 0.02% | +4,869+1.4% | Added |
| Massachusetts Financial Services Co | 333,080 | $11.4M | 0.00% | −2,432−0.7% | Reduced |
| Velan Capital Investment Management LP | 293,385 | $10.0M | 8.39% | +293,385 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 277,754 | $9.51M | 0.15% | 00.0% | Unchanged |
| Pier Capital, LLC | 237,776 | $8.14M | 0.86% | +159,262+202.8% | Added |
| Principal Financial Group Inc | 234,439 | $8.03M | 0.00% | +49,514+26.8% | Added |
| Artal Group S.A. | 200,000 | $6.85M | 0.20% | 00.0% | Unchanged |
| Rathbone Brothers plc | 190,015 | $6.51M | 0.06% | +190,015 | New |
| Paradigm Biocapital Advisors LP | 134,249 | $4.60M | 1.31% | +134,249 | New |
| Rhenman & Partners Asset Management AB | 90,000 | $3.07M | 0.20% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 64,000 | $2.19M | 0.44% | 00.0% | Unchanged |
| Omega Fund Management, LLC | 51,535 | $1.76M | 0.25% | 00.0% | Unchanged |
| Alps Advisors Inc | 50,670 | $1.74M | 0.02% | −2,993−5.6% | Reduced |
| Vident Investment Advisory, LLC | 30,676 | $1.05M | 0.03% | +30,676 | New |
| TD Asset Management Inc | 27,506 | $942.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 24,120 | $826.0K | 0.00% | +24,120 | New |
| Legal & General Group Plc | 22,369 | $765.0K | 0.00% | −2,908−11.5% | Reduced |
| Pura Vida Investments, LLC | 19,071 | $653.0K | 0.07% | −30,929−61.9% | Reduced |
| ETF Managers Group, LLC | 13,485 | $460.0K | 0.01% | −2,807−17.2% | Reduced |
| Point72 Asset Management, L.P. | 12,400 | $425.0K | 0.00% | −136,600−91.7% | Reduced |
| Citadel Advisors LLC | 12,123 | $415.0K | 0.00% | −10,405−46.2% | Reduced |
| UBS Group AG | 9,445 | $323.0K | 0.00% | −4,556−32.5% | Reduced |
| Victory Capital Management Inc | 8,186 | $280.0K | 0.00% | −1,342−14.1% | Reduced |
| State Street Corp | 6,316 | $216.0K | 0.00% | +116+1.9% | Added |
| Geode Capital Management, LLC | 5,997 | $205.0K | 0.00% | 00.0% | Unchanged |
| Virtus ETF Advisers LLC | 5,523 | $189.0K | 0.07% | +164+3.1% | Added |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 3,864 | $132.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 3,558 | $121.0K | 0.00% | +1,305+57.9% | Added |
| Morgan Stanley | 1,405 | $48.0K | 0.00% | −916−39.5% | Reduced |
| Rockefeller Capital Management L.P. | 1,000 | $34.0K | 0.00% | +1,000 | New |
| Veritas Investment Partners (UK) Ltd. | 575 | $20.0K | 0.00% | +575 | New |
| State of Wyoming | 136 | $5.00K | 0.00% | −7−4.9% | Reduced |
| Advisor Group Holdings, Inc. | 144 | $5.00K | 0.00% | +21+17.1% | Added |
| Tower Research Capital LLC (TRC) | 19 | $1.00K | 0.00% | +19 | New |
| Point72 Hong Kong Ltd | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Kayne Anderson Rudnick Investment Management LLC | 3 | $0 | 0.00% | +3 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −93,812−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −6,826−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −4,250−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −4,235−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Marshall Wace North America L.P. | – | – | – | – | Not filed |